Kathleen Scott - 04 Jan 2024 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Director
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Issuer symbol
DRMA
Transactions as of
04 Jan 2024
Net transactions value
$0
Form type
4
Filing time
05 Jan 2024, 21:01:59 UTC
Previous filing
04 Jan 2024
Next filing
14 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 04 Jan 2024 Common Stock 10,000 $0.6099 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments commencing January 4, 2024.